Financial Data and Key Metrics Changes - As of December 31, 2025, the loan portfolio principal totaled approximately $411 million across 26 portfolio companies, with a weighted average yield to maturity of 16.3%, down from 16.5% in the third quarter [12] - Net interest income for the fourth quarter was $14.2 million, a 4% increase from $13.7 million in the third quarter, primarily due to the collection of past due interest [18] - Total leverage was 32% of book equity as of December 31, compared to 33% as of September 30 [16] Business Line Data and Key Metrics Changes - Gross originations during the fourth quarter were approximately $19 million, with $5 million advanced to a new borrower and $14 million to existing borrowers [12] - The portfolio consisted of 37.6% fixed-rate loans and 62.4% floating-rate loans, with only 9% exposed to further rate declines [13][14] Market Data and Key Metrics Changes - The current pipeline stands at $616 million, indicating strong demand for debt capital in the cannabis sector [9] - The company has not experienced an over-allocation of capital, which is leading to compressed yields in other sectors of private credit [9] Company Strategy and Development Direction - The company focuses on the cannabis sector, leveraging its expertise to make debt investments in an industry with limited sources of debt capital [5] - The strategy is built on a disciplined focus on credit and collateral, with a strong emphasis on risk management [9] - The company aims to maintain a dividend payout ratio based on distributable earnings per share of 90%-100% for the 2026 tax year [22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the current environment, noting a strong pipeline and the potential for improved industry economics due to recent policy changes [10] - The company underwrites every investment assuming no regulatory-driven credit improvements, maintaining a conservative approach to risk [11] Other Important Information - The company has distributed $8.47 per common share in dividends since inception, representing an annualized yield on cost of approximately 12.4% [20] - The company received a total of $40.4 million in loan repayments, including early prepayments [21] Q&A Session Summary Question: Can you provide insight into the pipeline and potential net portfolio growth? - Management indicated confidence in achieving net portfolio growth, although liquidity is currently constrained relative to the pipeline [25] Question: How has rescheduling impacted current yields and underwriting? - Rescheduling has increased demand for debt capital but has not changed pricing or underwriting standards [27] Question: Are the new non-accrual loans in Arizona related to the same sponsor? - Yes, the loans are related to the same sponsor, who is navigating a challenging pricing environment [33] Question: Can you explain the logic behind lending more to a troubled borrower? - The company supported the borrower through a recapitalization and acquisition of additional dispensaries, improving cash flow and allowing the borrower to become current on interest [37] Question: What were the reasons for early repayments on certain loans? - Loan number 1 was refinanced with a new credit facility, while loan number 27 was paid off without pursuing refinancing due to various considerations [43]
Chicago Atlantic Real Estate Finance(REFI) - 2025 Q4 - Earnings Call Transcript